Full-Scale C-Reactive Protein Detection Reagent (CRP)
CRP overview
C-reactive protein (CRP) is a cyclic pentameric protein. The CRP
concentration in the blood of normal people is very low, but under
stress conditions such as infection, trauma, surgery, tissue
necrosis, and acute inflammation, the CRP concentration rises
sharply; in the absence of inflammation, hypersensitivity CRP is an
atherosclerotic thrombus The formed mediators and markers can be
used to monitor potential cardiovascular risks and assist in the
diagnosis of cardiovascular diseases.
CRP clinical significance
- Identification of infection (identification of bacterial and viral
infection)
- Guide the use of antibiotics
- Evaluation of cardiovascular disease risk index for auxiliary
diagnosis
- It indicates the prognosis
Application of full-scale C-reactive protein
Conventional C-reactive protein: monitoring of postoperative
infections and complications; monitoring of inflammation treatment,
monitoring of antibiotic use, etc.; differential diagnosis of
bacterial/viral infections.
High sensitivity C-reactive protein:As the most powerful predictor
of cardiovascular disease, it can predict the risk index of
myocardial infarction, coronary heart disease, stroke and other
diseases; Differential diagnosis of neonatal infection.
Child
| Test results | Clinical application recommendations |
|---|
| ＞25 | Bacterial infections |
| 10～25 | It is suggested that in the antibiotic treatment of viral
infection, CRP should be reduced below this level. If the course of
the disease is short and the bacterial infection cannot be ruled
out, it should be reviewed in a few hours |
| ＜10 | If the course of the disease exceeds 6-12 hours, bacterial
infection or bacterial removal can basically be ruled out |
Newborn (1～6 months)
| ＞2 | Prompt neonatal infection |
|---|
| Concentration drop | The treatment was effective and the condition improved( D4 ↓≥40% )
The antibiotic treatment was interrupted when the blood pressure
dropped to normal |
Adult
| Test results | Clinical application recommendations |
|---|
| ＞10 | Prompt bacterial infection, virus infection can be ruled out |
| 0 50～100 | Often bacterial infections, viral infections are not common |
| 25～50 | Prompt bacterial or viral infection |
| 10～25 | Prompt for viral infection. CRP should drop below this level during
antibiotic treatment. If the course of the disease is short and
bacterial infection cannot be ruled out, it should be reviewed in a
few hours. |
| 3～10 | Cardiovascular disease: high risk, it is recommended to give
anti-inflammatory and antithrombotic treatment at the same time |
| 1～3 | Cardiovascular disease: moderate risk, anti-inflammatory treatment
is recommended. Check again after two weeks and take the average
value as the basis of observation |
| ＜1 | Cardiovascular disease: low risk |
| Treatment goals | hsCRP ＜1mg/L |
Clinical comparison of CRP
Company profile
Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise
engaged in the research and development, production and operation
of in vitro diagnostic products. The in vitro diagnostic products
developed by the company cover POCT series, microbial series,
biochemical series and immune series reagents and supporting
instruments.
The company has always adhered to the core concept of "fast and
accurate, living up to life", committed to providing society with
excellent products and services, and contributing to the cause of
human health.
